Tuesday January 28, 2020

Price of new Hep C drugs ‘unsustainably high’

Manufacturers charging HSE between €45,000 and €80,000 for 12-week courses

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
13th March, 2016

The Irish Haemophilia Society has urged the HSE to initiate a public tender to source new medicines to cure Hepatitis C.

The organisation’s chief executive Brian O’Mahony said the price being charged by manufacturers in Ireland for the newest HepC medicines was “unsustainably high.”

Manufacturers are charging the HSE between €45,000 and €80,000 for a 12-week course of the new medicines in various combinations, with a cure rate of...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The three main parties’ election manifestos are big on promises but short on details when it comes to reforming health, and it’s sure to cause headaches for any incoming government

Susan Mitchell | 2 days ago

Board earmarked funds to enhance claims management and save money over life of project

Peter O'Dwyer | 2 days ago

The genetic data harvesting company posted the results as calls were made for the Irish government to appoint a genomics medicine guru

Killian Woods | 2 days ago